Why Shire's market cap is up eight-fold in 10 years
Investors should buy into the long-term momentum at leading biotechnology firm Shire (SHP). Now one of the 15 largest companies on the FTSE 100, its market cap has surged eight-fold from approximately £5bn to £43.7bn over the...
19 January 2017
